|
|
We at Medical Diversity Support(MDS) aim to provide medical opportunities to all people,
in addition to
safely deliver
the
modern
medical cares of the world.
Providing medical opportunities to all people
For Clinic doctors & patients
In Japan,the approval and sales medical
supplies
developed and approved in Europe and America requires
an extremely long period of time. This is the so called
‘drug lag’ phenomenon. As a result, although the medical supply may be verified of its safety overseas, the current
situation does not
allow Japanese patients to receive new drugs in a timely manner.
Medical Diversity Support provides such medical supplies (new drugs, generics) to customers through supporting
private
importation.
|
|
Because of “drug lag”phenomenon , people started to purchase un-upproval drug by internet website.
This is
the part of risk for Medical Manufacture since they may loose their traceability of the products.
We support Manufacture side by correcting customer information and having reporting system to them.
We work as agent
of Medical Manufacture who is interested in Japanese Medical Market to be as a
bridge
between Clinic doctors
and Manufacture. |
|
In the case of private importation, the Japanese domestic legislation (Pharmaceutical Affairs Law,
Customs Law)
in addition to the complicated administrative procedures accompanied, must be understood.
At Medical Diversity Support, support is given for procedures including correspondence of Japanese
domestic legislation, customs
clearing, and domestic delivery, and the products delivered safely and
swiftly based on the acquisition of the
Import Permit Report issued by the Ministry of Health, Labour, and Welfare. |
|
Are you planning investigation of your company medicine & medical devices which is not approved yet in Japan? |
Do you need support for market research or Sales developing?
If yes, Please E-mail us, we will support your company business. |
|
|
|